Jiancheng Ding - School of Pharmaceutical Sciences, Xiamen University

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 38 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A CARM1 Inhibitor Potently Suppresses Breast Cancer Both in Vitro and in Vivo

Bing-ling Peng,Ting Ran, Xue Chen,Jian-cheng Ding, Zi-rui Wang,Wen-juan Li,Wen Liu

JOURNAL OF MEDICINAL CHEMISTRYno. 10 (2024): 7921-7934

引用0浏览0WOS引用

CARM1 Hypermethylates the NuRD Chromatin Remodeling Complex to Promote Cell Cycle Gene Expression and Breast Cancer Development

Xue Chen,Ming-feng Huang, Da-meng Fan,Yao-hui He,Wen-juan Zhang,Jian-cheng Ding,Bing-ling Peng,Xu Pan, Ya Liu,Jun Du,Ying Li,Zhi-ying Liu,Bing-lan Xie,Zhi-jian Kuang,Jia Yi,Wen Liu

NUCLEIC ACIDS RESEARCH（2024）

引用0浏览0WOS引用

LncRNA LUESCC Promotes Esophageal Squamous Cell Carcinoma by Targeting the Mir-6785-5p/nrsn2 Axis

Song-tao Xue,Shi-qiang Cao,Jian-cheng Ding,Wen-juan Li,Guo-sheng Hu,Jian-cong Zheng,Xiao Lin,Chun Chen,Wen Liu,Bin Zheng

CELLULAR AND MOLECULAR LIFE SCIENCESno. 1 (2024)

引用0浏览0WOS引用

Targeting the PHF8/YY1 Axis Suppresses Cancer Cell Growth Through Modulation of ROS

Xiao- Nan Wu,Jia- yuan Li, Qi He,Bo-qun Li,Yao-hui He,Xu Pan,Ming- yue Wang, Rui Sang,Jian- cheng Ding,Xiang Gao,Zhen Wu,Wen Liu

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 2 (2024)

引用2浏览0WOS引用

Supplementary Table 1 from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

Lin Xia,Zaozao Zheng,Jun-yi Liu,Yu-jie Chen,Jiancheng Ding,Guo-sheng Hu,Ya-hong Hu,Suling Liu,Wen-xin Luo,Ning-shao Xia,Wen Liu

crossref（2023）

引用0浏览0引用

Estrogen-Induced LncRNA, LINC02568, Promotes Estrogen Receptor-Positive Breast Cancer Development and Drug Resistance Through Both in Trans and in Cis Mechanisms

Xue Chen,Jian-cheng Ding,Guo-sheng Hu, Xing-yi Shu, Yan Liu,Jun Du, Zi-jing Wen,Jun-yi Liu,Hai-hua Huang,Guo-hui Tang,Wen Liu

Advanced scienceno. 25 (2023)

引用0浏览0WOS引用

ER-localized JmjC Domain-Containing Protein JMJD8 Targets STING to Promote Immune Evasion and Tumor Growth in Breast Cancer

Jia Yi,Lei Wang,Jiao Du, Mingyue Wang,Haifeng Shen,Zhiying Liu,Yao Qin,Jing Liu,Guosheng Hu,Rongquan Xiao,Jiancheng Ding,Xiaoyan Chen, Hongjiao Wang,Haihua Huang,Gaoliang Ouyang,Wen Liu

Developmental cellno. 9 (2023): 760-778.e6

引用2浏览0WOS引用

Supplementary Figures from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

Lin Xia,Zaozao Zheng,Jun-yi Liu,Yu-jie Chen,Jiancheng Ding,Guo-sheng Hu,Ya-hong Hu,Suling Liu,Wen-xin Luo,Ning-shao Xia,Wen Liu

crossref（2023）

引用0浏览0引用

MAVI1, an Endoplasmic Reticulum-Localized Microprotein, Suppresses Antiviral Innate Immune Response by Targeting MAVS on Mitochondrion

Tao-tao Shi,Ying Huang,Ying Li, Xiang-long Dai,Yao-hui He,Jian-cheng Ding,Ting Ran,Yang Shi,Quan Yuan,Wen-juan Li,Wen Liu

Science Advancesno. 35 (2023)

引用4浏览0WOSSCIENCE引用

A Deregulated M6a Writer Complex Axis Driven by BRD4 Confers an Epitranscriptomic Vulnerability in Combined DNA Repair-Targeted Therapy

Xiao Lu,Lichao Peng,Jiancheng Ding,Yuanpei Li,Qing Li, Mengchen Rao,Tong Shu,Xiaoniu He, Chen Liu,Jing Ye,Wen Liu,Han You

Proceedings of the National Academy of Sciences of the United States of America（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn